🇺🇸 FDA
Patent

US 10821178

Methods of treating biofilm infections comprising administering inhibitors of myeloid-derived suppressor cells

granted A61KA61K38/1841A61K38/191

Quick answer

US patent 10821178 (Methods of treating biofilm infections comprising administering inhibitors of myeloid-derived suppressor cells) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/1841, A61K38/191, A61K38/2066, A61K38/217